Relmada Therapeutics, Inc.
Events
Join us on Apr 28 at 4:30pm ET for a virtual event on topline efficacy and safety data from the Phase 2 study evaluating NDV-01 for the treatment
of HG-NMIBC
Register at www.lifescievents.com/event/relmada